Intercure Ltd.
Produces and distributes GMP-certified, pharmaceutical-grade medical cannabis products.
INCR | TA
Overview
Corporate Details
- ISIN(s):
- IL0011063760
- LEI:
- 549300KI5ESXF8F5GP06
- Country:
- Israel
- Address:
- 11 USSISHKIN STREET, 3844346 HADERA
- Website:
- https://www.intercure.co
- Sector:
- Manufacturing
Description
Intercure Ltd. is a company focused on the production and distribution of pharmaceutical-grade medical cannabis and cannabis-based products. Operating primarily through its wholly-owned subsidiary, Canndoc Ltd., the company is a licensed producer of Good Manufacturing Practice (GMP) certified medical cannabis. Intercure's strategy involves international expansion through strategic partnerships, such as producing and distributing established brands like Cookies in European markets, and through acquisitions to access premium technologies and brands. The company leverages its EU-GMP certified manufacturing facilities to supply its products for medical use across its operational territories.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-09-13 19:54 |
An Extraordinary General Meeting of Shareholders will be held on October 28, 20…
|
English | 359.3 KB | ||
| 2024-09-13 19:54 |
An Extraordinary General Meeting of Shareholders will be held on October 28, 20…
|
English | 130.8 KB | ||
| 2024-08-30 02:25 |
Financial results for the six months ended June 30, 2024
|
English | 193.9 KB | ||
| 2024-08-30 02:25 |
Financial results for the six months ended June 30, 2024
|
English | 36.2 KB | ||
| 2024-08-28 17:49 |
FORM 6-K-InterCure Announces Expansion of its Strategic partnership with Cookie…
|
English | 152.5 KB | ||
| 2024-08-28 17:49 |
FORM 6-K-InterCure Announces Expansion of its Strategic partnership with Cookie…
|
English | 36.2 KB | ||
| 2024-05-22 01:47 |
InterCure Provides Update Following Class Action Dismissal
|
English | 139.3 KB | ||
| 2024-05-22 01:47 |
InterCure Provides Update Following Class Action Dismissal
|
English | 36.3 KB | ||
| 2024-05-01 16:27 |
InterCure Announces FY2023 Result
|
English | 177.5 KB | ||
| 2024-05-01 16:27 |
InterCure Announces FY2023 Result
|
English | 36.2 KB | ||
| 2024-05-01 16:23 |
FORM 20-F For the fiscal year ended December 31, 2023
|
English | 2.2 MB | ||
| 2024-05-01 16:23 |
FORM 20-F For the fiscal year ended December 31, 2023
|
English | 36.2 KB | ||
| 2024-04-01 18:12 |
Preliminary results for the full year of 2023
|
English | 189.4 KB | ||
| 2024-04-01 18:12 |
Preliminary results for the full year of 2023
|
English | 36.2 KB | ||
| 2024-02-14 00:57 |
InterCure Provides an Update Regarding Nir Oz Facility
|
English | 140.1 KB |
Automate Your Workflow. Get a real-time feed of all Intercure Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Intercure Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Intercure Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
